Literature DB >> 11557116

The prognostic significance of malignant pleural effusion at the time of thoracotomy in patients with non-small cell lung cancer.

T Fukuse1, T Hirata, F Tanaka, H Wada.   

Abstract

Surgery is usually not indicated for malignant pleural effusion (PE) due to its poor prognosis. However, PE is first detected at thoracotomy, and it is difficult to judge an appropriate mode of resection. Forty-nine patients with lung cancer were first diagnosed as PE and/or pleural dissemination (PD) at thoracotomy. The histological types were 36 adenocarcinoma, ten squamous cell carcinoma and three large cell carcinoma. Sixteen patients had only PE, 17 had only PD, and 16 had both PE and PD. Ten patients underwent only exploratory thoracotomy, seven partial resection, 27 lobectomy and five panpleuropneumonectomy. The overall survival rate was 26.7% at 3 years. The patients with PE and/or PD seemed to have a poorer survival compared to our previous study. The patients with only PE showed a significantly better prognosis than the patients with only PD (P=0.0001) or with PD+PE (P=0.019). The patients who underwent exploratory thoracotomy showed poor survival. There were significant differences in the survival in relation to the extent of the primary tumor. In conclusion, the patients with T1-2 of primary tumor and only a small amount of PE without PD can be expected to show long-term survival after tumor resection.

Entities:  

Mesh:

Year:  2001        PMID: 11557116     DOI: 10.1016/s0169-5002(01)00228-8

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  15 in total

Review 1.  In lung cancer patients where a malignant pleural effusion is found at operation could resection ever still be justified?

Authors:  Alfonso Fiorelli; Mario Santini
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-05-08

2.  Pulmonary resection for lung cancer with malignant pleural disease first detected at thoracotomy.

Authors:  Tatsuro Okamoto; Takekazu Iwata; Teruaki Mizobuchi; Hidehisa Hoshino; Yasumitsu Moriya; Shigetoshi Yoshida; Ichiro Yoshino
Journal:  Eur J Cardiothorac Surg       Date:  2012-01       Impact factor: 4.191

Review 3.  The Role of Thoracic Surgery in the Therapeutic Management of Metastatic Non-Small Cell Lung Cancer.

Authors:  Elizabeth A David; James M Clark; David T Cooke; Joy Melnikow; Karen Kelly; Robert J Canter
Journal:  J Thorac Oncol       Date:  2017-08-24       Impact factor: 15.609

Review 4.  The role of surgical intervention in lung cancer with carcinomatous pleuritis.

Authors:  Takayuki Fukui; Kohei Yokoi
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

5.  Primary tumour resection showed survival benefits for non-small-cell lung cancers with unexpected malignant pleural dissemination.

Authors:  Yi-Jiu Ren; Yun-Lang She; Chen-Yang Dai; Ge-Ning Jiang; Ke Fei; Chang Chen
Journal:  Interact Cardiovasc Thorac Surg       Date:  2015-12-24

6.  Accidental invisible intrathoracic disseminated pT4-M1a: a distinct lung cancer with favorable prognosis.

Authors:  Wen-Zhao Zhong; Wei Li; Xue-Ning Yang; Ri-Qiang Liao; Qiang Nie; Song Dong; Hong-Hong Yan; Xu-Chao Zhang; Hai-Yan Tu; Bin-Chao Wang; Jian Su; Jin-Ji Yang; Qing Zhou; Yi-Long Wu
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

7.  Management of occult malignant pleural disease firstly detected at thoracotomy for non-small cell lung cancer patients.

Authors:  Shaolei Li; Shanyuan Zhang; Miao Huang; Yuanyuan Ma; Yue Yang
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

8.  The prognosis after contraindicated surgery of NSCLC patients with malignant pleural effusion (M1a) may be better than expected.

Authors:  Yijiu Ren; Chenyang Dai; Jianfei Shen; Yang Liu; Dong Xie; Hui Zheng; Jiaxi He; Wenhua Liang; Gening Jiang; Ke Fei; Ping Yang; Jianxing He; Chang Chen
Journal:  Oncotarget       Date:  2016-05-03

9.  Surgical Resection of Primary Tumors Provides Survival Benefits for Lung Cancer Patients With Unexpected Pleural Dissemination.

Authors:  Liwen Fan; Haitang Yang; Ke Han; Yang Zhao; Wen Gao; Ralph A Schmid; Feng Yao; Heng Zhao
Journal:  Front Surg       Date:  2021-06-23

Review 10.  New horizons in non-small-cell lung cancer patients with ipsilateral pleural dissemination (M1a): review of the literature.

Authors:  Hao Li; Taorui Liu; Zewen Sun; Zhenfan Wang; Xianping Liu; Fan Yang
Journal:  Ann Transl Med       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.